Lambert Skoog

ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS

Tommy� Fornander, Björn Cedermark, Anders Mattsson et al. · The Lancet · 1989 · 930 citations

Breast Oncology, Medicine, Gynecology +5

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

Yudi Pawitan, Judith Bjöhle, Lukas C. Amler et al. · Breast Cancer Research · 2005 · 816 citations · Full text

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

Linda S. Lindström, Eva Karlsson, Ulla Wilking et al. · Journal of Clinical Oncology · 2012 · 517 citations

Hormonal Receptors, Breast Oncology, Progesterone Receptor +15

Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer

Barbro Linderholm, Henrik Hellborg, Unn‐Britt Johansson et al. · Annals of Oncology · 2009 · 339 citations

Surgical Oncology, Breast Oncology, Higher Levels +10

Novel patterns of genome rearrangement and their association with survival in breast cancer

James Hicks, Alexander Krasnitz, B. Lakshmi et al. · Genome Research · 2006 · 322 citations · Full text

High Resolution, Breast Oncology, Genetics +20